The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rapid and deep prostate-specific antigen (PSA) response to apalutamide plus ADT and survival in metastatic castration-sensitive prostate cancer (mCSPC) in real world practice in the US (OASIS Project).
 
Benjamin L. Maughan
Consulting or Advisory Role - Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Janssen Oncology; Merck; Peloton Therapeutics; Pfizer; Tempus
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Yanfang Liu
Employment - Johnson & Johnson LLC
Stock and Other Ownership Interests - Johnson & Johnson LLC
 
Suneel Mundle
Employment - Johnson & Johnson LLC
Stock and Other Ownership Interests - Johnson & Johnson LLC
 
Xiayi Wang
Employment - Johnson & Johnson LLC
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical
Honoraria - Astellas, Astra-Zeneca, Abbvie, Bayer, Dendreon, Janssen, Merck, Myovant, Pfizer, and Sanofi
Consulting or Advisory Role - Astellas, Astra-Zeneca, Abbvie, Bayer, Bristol Myers Squibb, Ferring, Dendreon, Janssen, Merck, Myovant, Pfizer, Sanofi
Speakers' Bureau - Astellas, Astra-Zeneca, Bayer, Dendreon, Janssen, Merck, Myovant, and Pfizer
Research Funding - Janssen, Bayer, Bristol Myers Squibb, Dendreon, Epizyme, Astellas, Pfizer, Astra-Zeneca, BioExcel, Vaxiion, Kdx, OncoCell, Neuspera, Myovant, and Cleveland Diagnostics (Inst)